Language selection

Search

Patent 2989926 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2989926
(54) English Title: NON-CARCINOGENIC CREAM FOR DELIVERY OF ACTIVE INGREDIENT INTO THE DERMIS
(54) French Title: CREME NON CANCEROGENE DESTINEE A LA LIBERATION D'INGREDIENT ACTIF DANS LE DERME
Status: Granted and Issued
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 47/44 (2017.01)
  • A61K 9/10 (2006.01)
  • A61K 33/00 (2006.01)
  • A61K 36/00 (2006.01)
  • A61K 47/14 (2017.01)
  • A61K 47/46 (2006.01)
  • A61P 7/00 (2006.01)
  • A61P 17/02 (2006.01)
  • A61P 19/02 (2006.01)
(72) Inventors :
  • GLEN, SAMUEL (Canada)
  • JOHNSTON, BARBARA J. (Canada)
  • SHARMA, MOLLY (Canada)
  • THERRIEN BERTHIAUME, LYNDA (Canada)
(73) Owners :
  • PRODUITS NATURASENCE INC.
(71) Applicants :
  • PRODUITS NATURASENCE INC. (Canada)
(74) Agent: BENOIT & COTE INC.
(74) Associate agent:
(45) Issued: 2024-01-02
(22) Filed Date: 2017-12-22
(41) Open to Public Inspection: 2019-06-22
Examination requested: 2021-06-25
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract

The present document describes a non-carcinogenic cream for delivery of active ingredients in the dermis of a patient, which comprises a synergistic combination of .cndot. about 10 to 25% of oil .cndot. about 10 to 25% of emulsifier .cndot. about 1 to 12% of preservative .cndot. about 45 to 80% of water, aloe water or hamamelis water; and .cndot. about 1 to 25% of at least one homeopathic active ingredient chosen from pancreatinum, ruta graveolens, ledum palustre, colchicum autumnale, symphytum officinalis, salix alba, harpagophytum, bryonia, capsicum, rhododendron, benzoic acid, salicilicum acid, arnica montana, atropa belladonna, achillea millefolium, hamamelis, agaricus, aesculus, mercurius solubilis, mercurius iodatus, conium maculatum, echinacea angustifolia, echinacea purpurea, scrofularia nosada, pulsatilla, aconitum napellus, hypericum perforatum, bellis perennis, matricaria chamomilla, ranunculus, phytolacca decandra, dulcamara solanum, kalmia, actea racemosa, spigelia, gnaphalium, calendula officinalis, hepar sulphuris, somniferrum, calcarea fluorica, thiosinaminum, hydrastis, arctium lappa, gallium aparine, urtica urens, aloe, graphite, petroleum or a synergistic combination thereof.


French Abstract

Le présent document décrit une crème non cancérogène destinée à la libération dingrédients actifs dans le derme dun patient, ladite crème comprenant une combinaison synergétique de .cndot. environ 10 à 25 % dhuile .cndot. environ 10 à 25 % démulsifiant .cndot. environ 1 à 12 % de préservatif .cndot. environ 45 à 80 % deau, deau daloès ou deau dhamamélis; et .cndot. environ 1 à 25 % dau moins un ingrédient actif homéopathique sélectionné parmi le Pancreatinum, le Ruta graveolens, le Ledum palustre, le Colchicum autumnale, le Symphytum officinalis, le Salix alba, lHarpagophytum, le Bryonia, le Capsicum, le rhododendron, lacide benzoïque, lacide salicylique, lArnica montana, lAtropa belladonna, lAchillea millefolium, lHamamelis, lAgaricus, lAesculus, le Mercurius solubilis, le Mercurius iodatus, le Conium maculatum, lEchinacea angustifolia, lEchinacea purpurea, le Scrofularia nosada, le Pulsatilla, lAconitum napellus, lHypericum perforatum, le Bellis perennis, le Matricaria chamomilla, le Ranunculus, le Phytolacca decandra, le Dulcamara solanum, le Kalmia, lActea racemosa, le Spigelia, le Gnaphalium, le Calendula officinalis, lHepar sulphuris, le Somniferrum, le Calcarea fluorica, le Thiosinaminum, lHydrastis, lArctium lappa, le Gallium aparine, lUrtica urens, laloès, le graphite, le pétrole ou une combinaison synergétique de ces ingrédients.

Claims

Note: Claims are shown in the official language in which they were submitted.


CLAIMS:
1. A
cream for delivery of active ingredients in the derm is of a patient, which
comprises a combination of
= about 10 to about 25% by weight of oil
= about 10 to about 25% by weight of emulsifier
= about 1 to about 12% by weight of preservative
= about 45 to about 80% by weight of water, aloe water or hamamelis water;
and
= about 1 to about 25% by weight of a combination of at least five
homeopathic active
ingredients comprising:
O a first ingredient for improving joint conditions chosen from one of ruta
graveolens, ledum palustre, colchicum autumnale, symphytum
officinalis, salix alba, harpagophytum, bryonia, capsicum,
rhododendron, benzoic acid, salicilicum acid or a combination thereof;
O a second ingredient for improving blood circulation chosen from one of
arnica montana, atropa belladonna, achillea millefolium, hamamelis,
agaricus, aesculus or a combination thereof;
O a third ingredient for improving lymphatic circulation chosen from one of
mercurius solubilis, mercurius iodatus, conium maculatum, echinacea
angustifolia, echinacea purpurea, gallium aparine, phytolacca decandra,
scrofularia nosada, pulsatilla, or a combination thereof;
O a fourth ingredient for improving sensitive nerves chosen from aconitum
napellus, hypericum perforatum, bellis perennis, matricaria chamomilla,
ranunculus, phytolacca decandra, dulcamara solanum, kalmia, actea
racemosa, spigelia, gnaphalium, or a combination thereof; and
O a fifth ingredient for reducing scars and/or keloids of the skin chosen
from pancreatinum, calendula officinalis, hepar sulphuric, somniferrum,
calcarea fluorica, thiosinaminum, hydrastis, arctium lappa, gallium
aparine, urtica urens, aloe, graphite, petroleum or a combination thereof.
12
Date recue/Date received 2023-06-05

2. The cream of claim 1, wherein the oil is at least one oil chosen from
emu oil, olive
oil, argan nut oil, sunflower/safflower oil, coconut oil, castor oil, avocado
oil, jojoba oil,
lavender oil, grape seed oil, poppy seed oil, sunflower oil or wheat germ oil.
3. The cream of any one of claims 1 to 2, wherein the emulsifier is at
least one chosen
from oleyl oleate, cetearyl alcohol, cetearyl wheat straw glucosides, glyceryl
stearate,
sodium stearoyl lactylate, cetearyl olivate, sorbitan olivate, propylene
glycol esters, borax
with bees wax, bees wax, BTMS 25%, carbomer, emulsifying wax¨NF, lecithin,
stearate,
silky emulsifying wax, stearyl alcohol NF, shea butter, cocoa butter, coconut
oil or stearic
acid.
4. The cream of any one of claims 1 to 3, wherein the preservative is at
least one
chosen from a combination of glucose, glucose oxidase and lactoperoxidase, a
combination of benzyl alcohol, salicylic acid, glycerin and sorbic acid,
polylysine,
natamycin, nisin, isothiazolinones, benzoic acid ¨ sodium benzoate, sorbic
acid -
potassium sorbate, levulinic acid, anisic acid, rosemary oil extract,
grapefruit seed extract,
T-50 vitamin E oil, germaben TM 11, or germaben TM 11-E.
5. The cream of any one of claims 1 to 4, which comprises
= about 14% by weight of oil;
= about 14% by weight of emulsifier;
= about 1% by weight of preservative; and
= about 66% by weight of water; and
= about 5% by weight of the homeopathic active ingredient which comprises
at least
pancreatinum, ruta graveolens, ledum palustre, colchicum autumnale, symphytum
officinalis, arnica montana, atropa belladonna, achillea millefolium,
hamamelis, mercurius
solubilis, mercurius iodatus, conium maculatum, echinacea angustifolia,
echinacea
purpurea, aconitum napellus, hypericum perforatum, bellis perennis, matricaria
chamomilla, calendula officinalis and hepar sulphuris.
13
Date recue/Date received 2023-06-05

6.
Use of the cream of any one of claims 1-5 as a topical-based treatment for
improving joint conditions, blood circulation, lymphatic circulation,
sensitive nerves, and
reducing scars and/or keloids of the skin and promoting granulation tissue
growth wherein
- joint conditions in a patient comprises pain, stiffness, sprain, strain,
swelling,
inflammation, wound and injury;
- blood circulation in a patient comprises pain, muscle elongations and/or
contractions, congestion, capillary distension, swelling, inflammation,
bruise,
wound and injury;
- lymphatic circulation in a patient comprises pain, congestion of lymphatic
system,
glandular swelling, bruise, stiffness, muscular weakness, lymphatic
inflammation,
wound and injury; and
- sensitive nerves conditions in a patient comprises pain, joint swelling,
irritation in
joint and/or muscle, nerve contraction, wound and injury.
14
Date Recue/Date Received 2023-09-20

Description

Note: Descriptions are shown in the official language in which they were submitted.


File No. P4334CA00
Title: NON-CARCINOGENIC CREAM FOR DELIVERY OF ACTIVE
INGREDIENT INTO THE DERMIS
BACKGROUND
(a) Field
[0001] The subject matter disclosed generally relates to a non-
carcinogenic cream for delivery of active ingredients into the dermis of a
patient for pain related to joint, lymphatic and blood circulation, nerve and
skin.
(b) Related Prior Art
[0002] Many pharmaceutical analgesic topical compositions for
treating
muscular cramps, soreness and pain contain irritants, counter-irritants and
toxic ingredients that are mostly carcinogenic and mask pain instead of
alleviating it. These compositions irritate the skin and do not treat all the
symptoms, causes pain and side effects and/or increase the risk of
developing cancer.
[0003] Homeopathy is an ancient healing art and forms a vital part
of
medical therapy. The practice of homeopathy is widespread, particularly in
eastern cultures and many European countries. Homeopathic medicine
teaches the use of natural based remedies and, as such, provides an
alternative to traditional allopathic medicine which relies heavily on the use
of
petrochemical based pharmaceuticals. There has been a large increase in
interest in homeopathic medicine in the United States in recent years due, in
large part, to a growing disenchantment with allopathic medications and the
complications and side effects arising from their use. Frequently, the
administration of allopathic medications results in serious side effects more
deleterious to the patient than the basic condition being treated. Today, more
and more individuals are looking for a gentler, safer path to good health free
of the risks and side effects associated with traditional allopathic
medicines.
[0004] In order to relieve pain in many inflammatory injuries or
diseases
it is desirable to promote healing, improve circulation to tissues nerves,
provide anti-inflammatory activity, while alleviating pain instead of masking
it.
1
CA 2989926 2017-12-22

File No. P4334CA00
Many injuries have a multiplicity of symptoms which require a cocktail of
ingredients working together in order to provide relief.
[0005] Furthermore, it is desirable to obtain deep penetration of the
active ingredients so as to act in the dermis to provide the proper response
to
cause healing of the injury and/or inflammation.
[0006] It is further desirable to provide an analgesic which does not
rely
upon counter-irritants that act by causing a superficial inflammation on the
skin, which numbs the sensation of pain perceived by the sensory organ and
results in only masking the pain instead of alleviating it.
[0007] It is further desirable to relax soft tissues, vasodilate
blood
vessels which are vasoconstricted so as to allow blood to flow normally,
returning nutrients and oxygen to areas to promote healing. It is also
desirable
to release nerves which have been entrapped by hypercontraction of muscle
tissue.
[0008] U.S. Pat. No. 5,162,037 to Whitson-Fischman discloses a
method for treating pathogenic conditions of the body by preparing a
homeopathic mixture of at least one herb or herbal extract which exhibits
therapeutic property and add a magnetically permeable substance to the
mixture, magnetizing the resulting mixture in a magnetic field during delivery
to impart a substantially unipolar magnetic charge on said mixture; and
administering the magnetized mixture through one or more specific
acupuncture points of the body which are associated with producing a desired
response to the particular condition being treated.
[0009] U.S. Pat. No. 5,795,573 to Paradise discloses homeopathic
topical anti-inflammatory and pain relieving compositions. Although the
compositions active ingredients include homeopathic extracts from Arnica
Montana, Rhus toxicodendron and Aesculus hippocastanum and belladonna,
they also include carcinogenic ingredients such as PEG, PPG,
ethoxydiglycol, paraben, isopropyl myristate and Dowicil 200TM
2
Date Recue/Date Received 2022-09-29

File No. P4334CA00
[0010] Finally, it is highly desirable to have a non-carcinogenic
cream
for the treatment of pain.
SUMMARY
[0011] It is an object of the present disclosure to provide a non-
carcinogenic cream for delivery of active ingredients in the dermis of a
patient
for pain related to joint, lymphatic and blood circulation, nerve and skin.
[0012] According to an embodiment, there is provided a non-
carcinogenic cream for delivery of active ingredients in the dermis of a
patient,
comprises a synergistic combination of
= about 10 to 25% of oil
= about 10 to 25 of emulsifier
= about 1 to 12% of preservative
= about 45 to 80% of water, aloe water or hamamelis water, and
= about 1 to 25% of at least one homeopathic active ingredient chosen
from pancreatinum, ruta graveolens, ledum palustre, colchicum autumnale,
symphytum officinalis, salix alba, harpagophytum, bryonia, capsicum,
rhododendron, benzoic acid, salicilicum acid, arnica montana, atropa
belladonna, achillea millefolium, hamamelis, agaricus, aesculus, mercurius
solubilis, mercurius iodatus, conium maculatum, echinacea angustifolia,
echinacea purpurea, scrofularia nosada, pulsatilla, aconitum napellus,
hypericum perforatum, bellis perennis, matricaria chamomilla, ranunculus,
phytolacca decandra, dulcamara solanum, kalmia, actea racemosa, spigelia,
gnaphalium, calendula officinalis, hepar sulphuris, somniferrum, calcarea
fluorica, thiosinaminum, hydrastis, arctium lappa, gallium aparine, urtica
urens, aloe, graphite, petroleum or a synergistic combination thereof.
[0013] The oil is chosen from emu oil, olive oil, argan nut oil,
sunflower/safflower oil, coconut oil, castor oil, avocado oil, jojoba oil,
lavender
oil, grape seed oil, poppy seed oil, sunflower oil or wheat germ oil.
[0014] The emulsifier is chosen from oleyl oleate, cetearyl
alcohol,
cetearyl wheat straw glucosides, glyceryl stearate, sodium stearoyl lactylate,
3
CA 2989926 2017-12-22

File No. P4334CA00
cetearyl olivate, sorbitan olivate, propylene glycol esters (pgms), borax with
bees wax, bees wax, BTMS 25%, carbomer, emulsifying wax¨NF, lecithin,
stearate, silky emulsifying wax, stearyl alcohol NF, shea butter, cocoa
butter,
coconut oil or stearic acid.
[0015] The preservative is chosen from a combination of glucose,
glucose oxidase and lactoperoxidase (BiovertTM enzymes), a combination of
benzyl alcohol, salicylic acid, glycerin and sorbic acid (GeoguardTM ECT),
polylysine, natamycin, nisin, isothiazolinones, benzoic acid ¨ sodium
benzoate, sorbic acid - potassium sorbate, levulinic acid, anisic acid,
rosemary oil extract, grapefruit seed extract, T-50 vitamin E oil, jermaben
11,
or jermaben 11-E.
[0016] The non-carcinogenic cream for improving joint conditions
contains at least one homeopathic active ingredient chosen from
pancreatinum, ruta graveolens, ledum palustre, colchicum autumnale,
symphytum officinalis, salix alba, harpagophytum, bryonia, capsicum,
rhododendron, benzoic acid, salicilicum acid or a synergistic combination
thereof.
[0017] The non-carcinogenic cream for improving blood circulation
contains at least one homeopathic active ingredient chosen from arnica
montana, atropa belladonna, achillea millefolium, hamamelis, agaricus,
aesculus or a synergistic combination thereof.
[0018] The non-carcinogenic cream for improving lymphatic
circulation
contains at least one homeopathic active ingredient chosen from mercurius
solubilis, mercurius iodatus, conium maculatum, echinacea angustifolia,
echinacea purpurea, gallium aparine, phytolacca decandra, scrofularia
nosada, pulsatilla or a synergistic combination thereof.
[0019] The non-carcinogenic cream for improving sensitive nerves
contains at least one homeopathic active ingredient chosen from aconitum
napellus, hypericum perforatum, bellis perennis, matricaria chamomilla,
4
CA 2989926 2017-12-22

File No. P4334CA00
ranunculus, phytolacca decandra, dulcamara solanum, kalmia, actea
racemosa, spigelia, gnaphalium or a synergistic combination thereof.
[0020] The non-carcinogenic cream for reducing scars and/or
keloids of
the skin contains at least one homeopathic active ingredient chosen from
pancreatinum, calendula officinalis, hepar sulphuris, somniferrum, calcarea
fluorica, thiosinaminum, hydrastis, arctium lappa, gallium aparine, urtica
urens, aloe, graphite, petroleum or a synergistic combination thereof.
[0021] The preferred non-carcinogenic cream comprises
= about 14.7% of oil;
= about 12.8% of emulsifier;
= about 1.05% of preservative; and
= about 65.67% of water; and
= about 4.78% the homeopathic active ingredient comprises at least
pancreatinum, ruta graveolens, ledum palustre, colchicum autumnale,
symphytum officinalis, arnica montana, atropa belladonna, achillea
millefolium, hamamelis, mercurius solubilis, mercurius iodatus, conium
maculatum, echinacea angustifolia, echinacea purpurea, aconitum napellus,
hypericum perforatum, bellis perennis, matricaria chamomilla, calendula
officinalis and hepar sulphur's.
[0022] According to another embodiment, there is provided a non-
carcinogenic cream for delivery of active ingredients in the dermis of a
patient
comprises a synergistic combination of
= about 10 to 25% of oil
= about 10 to 25 of emulsifier
= about 1 to 12% of preservative
= about 45 to 80% of water, aloe water or hamamelis water, and
= about 1 to 25% of a synergistic combination of at least five
homeopathic active ingredients comprising
CA 2989926 2017-12-22

File No. P4334CA00
O from at least one of aconitum napellus, hypericum perforatum,
bellis a first ingredient chosen from at least one of ruts graveolens,
ledum palustre, colchicum autumnale or symphytum officinalis;
O a second ingredient chosen from at least one of arnica montana,
atropa belladonna, achillea millefolium or hamamelis;
O a third ingredient chosen from at least one of mercurius solubilis,
mercurius iodatus, conium maculatum, echinacea angustifolia or
echinacea purpurea;
O a fourth ingredient chosen from at least one perennis, matricaria
chamomilla, gallium aparine, phytolacca decandra, scrofularia
nosada, or pulsatilla;
O a fifth ingredient chosen from at least one of pancreatinum,
calendula officinalis, hepar sulphuris, somniferrum, calcarea
fluorica, thiosinaminum, hydrastis, arctium lappa, gallium aparine,
urtica urens, aloe, graphite, or petroleum.
[0023] Features and advantages of the subject matter hereof will
become more apparent in light of the following detailed description of
selected
embodiments, as illustrated in the accompanying figures. As will be realized,
the subject matter disclosed and claimed is capable of modifications in
various respects, all without departing from the scope of the claims.
Accordingly, the drawings and the description are to be regarded as
illustrative in nature, and not as restrictive and the full scope of the
subject
matter is set forth in the claims.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0024] According to the invention, there is provided a non-
carcinogenic
cream for topical application for delivery of active ingredients in the dermis
of
a patient for pain related to joint, lymphatic and blood circulation, nerve
and
skin.
[0025] The composition can be used in combination with an
occlusive
bandage.
6
CA 2989926 2017-12-22

File No. P4334CA00
[0026] It has been found that the non-carcinogenic cream for
delivery of
active ingredients in the dermis of a patient for treating pain, includes a
synergistic combination of
= about 10 to 25% of oil
= about 10 to 25% of emulsifier
= about 1 to 12% of preservative
= about 45 to 80% of water, aloe water or hamamelis water; and
= about 1 to 25% of at least one homeopathic active ingredient chosen
from pancreatinum, ruta graveolens, ledum palustre, colchicum autumnale,
symphytum officinalis, arnica montana, atropa belladonna, achillea
millefolium, hamamelis, mercurius solubilis, mercurius iodatus, conium
maculatum, echinacea angustifolia, echinacea purpurea, aconitum napellus,
hypericum perforatum, bellis perennis, matricaria chamomilla, calendula
officinalis, hepar sulphuris or a synergistic combination thereof.
[0027] Although greater amounts of the homeopathic active
ingredient
can be used in the composition it has been found that about 2 to 25% by
weight of the combination of extracts is effective.
[0028] The compositions of the invention can be used in
combination
with other herbs or herbal extracts. For example, it may be desirable to thin
the blood or to better promote circulation such as Naja and Gratalus
horridum.
[0029] To condition the skin graphite and/or trace minerals such
as
copper and zinc salts may be included.
[0030] Other anti-inflammatory agents such as Lachesis Ninta that
contains enzymes which relieves muscle tightness and cramps can be
included in the composition.
[0031] The combinations as used herein stimulate the body's self
healing mechanism by promoting circulation in the micro-capillary system.
This restores blood flow to the inflammed areas where most of the pain is
7
CA 2989926 2017-12-22

File No. P4334CA00
realized. When blood flow is improved to an ailing joint, healing begins and
true pain relief is realized.
[0032] The compositions of the invention may include other plant
or
herbal extracts. For example, there may be utilized extracts of Paraguay tea,
Kola and Guarana which provide a source of methylxanthines, saponius,
tannins and glycosides which have been shown to reduce swelling and
redness. The extract of Paraguay tea is known as "Mate extract" and is
described in the "International Cosmetic Ingredient Dictionary", 5th Edition.
Mate extract is commercially available in combination with extracts of Kola
and Guarana which is sold by Cosmetic Ingredient Resources of Stamford
under the trademark "QUENCHT."
(0033] Suitable herbs which can be used also include symphytum,
officianalis, Moschus moscheferous, Cow bezoar, Pripalia geniculata,
Plantago asiatica, Causticum, Helianthemum canadense, Ornithogalum
umbellatum, Clematis crispa, Impatiens pallida, Prunus Cerasus, and the like.
[0034] The present invention will be more readily understood by
referring to the following examples which are given to illustrate the
invention
rather than to limit its scope. The amounts indicated are by weight percent
unless otherwise noted.
EXAMPLE 1
Cream to treat pain
(0035] A non-carcinogenic cream is prepared by admixing the
following
ingredients.
= 12.7% of a synergistic combination of emu oil, olive oil, argan nut oil,
sunflower/safflower oil and coconut oil;
= 15.8% of a synergistic combination of coleyl oleate and cetearyl
alcohol;
= 1.05% of a synergistic combination of glucose, glucose oxidase and
lactoperoxidase;
8
CA 2989926 2017-12-22

File No. P4334CA00
= 65.67% of water and
= 4.78% of a combination of homeopathic extracts containing:
O 0.05 % by weight of pancreatinum,
O 0.01% by weight of ruta graveolens,
O 0.01% by weight of ledum palustre,
O 0.1% by weight of colchicum autumnale,
O 0.1% by weight of symphytum officinal's,
O 1.5% by weight of arnica montana,
O 0.5% by weight of atropa belladonna,
O 0.07% by weight of achillea millefolium,
O 0.45% by weight of hamamelis,
O 0.04% by weight of mercurius solubilis,
O 0.01% by weight of mercurius iodatus,
O 0.1% by weight of conium maculatum,
o 0.15% by weight of echinacea angustifolia,
O 0.15% by weight of echinacea purpurea,
O 0.5% by weight of aconitum napellus,
O 0.09% by weight of hypericum perforatum,
o 0.1% by weight of bellis perennis,
O 0.15% by weight of matricaria chamomilla,
O 0.45% by weight of calendula officinalis and
O 0.25% by weight of hepar sulphuris.
EXAMPLE 2
Cream to treat pain
9
CA 2989926 2017-12-22

File No. P4334CA00
[0036] A non-
carcinogenic cream is prepared by admixing the following
ingredients.
= 14.7% of a synergistic combination of emu oil, olive oil, argon nut oil,
sunflower/safflower oil and coconut oil;
= 12.8% of a synergistic combination of oleyl oleate and cetearyl
alcohol;
= 1.05% of a synergistic combination of benzyl alcohol, salicylic acid,
glycerin and sorbic acid;
= 65.67% of water and
= 4.78% of a combination of homeopathic extracts containing:
O 0.05 % by weight of pancreatinum,
O 0.01% by weight of ruta graveolens,
o 0.01% by weight of ledum palustre,
O 0.1% by weight of colchicum autumnale,
O 0.1% by weight of symphytum offleinalis,
o 1.5% by weight of arnica montana,
O 0.5% by weight of atropa belladonna,
O 0.07% by weight of achillea millefolium,
= 0.45% by weight of hamamelis,
O 0.04% by weight of mercurius solubilis,
O 0.01% by weight of mercurius iodatus,
O 0.1% by weight of conium maculatum,
O 0.15% by weight of echinacea angustifolia,
O 0.15% by weight of echinacea purpurea,
O 0.5% by weight of aconitum napellus,
O 0.09% by weight of hypericum perforatum,
CA 2989926 2017-12-22

File No. P4334CA00
O 0.1% by weight of bellis perennis,
o 0.15% by weight of matricaria chamomilla,
O 0.45% by weight of calendula officinalis and
O 0.25% by weight of hepar sulphuris.
While preferred embodiments have been described above and illustrated in
the accompanying drawings, it will be evident to those skilled in the art that
modifications may be made without departing from this disclosure. Such
modifications are considered as possible variants comprised in the scope of
the disclosure.
11
CA 2989926 2017-12-22

Representative Drawing

Sorry, the representative drawing for patent document number 2989926 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Maintenance Request Received 2024-10-23
Maintenance Fee Payment Determined Compliant 2024-10-23
Inactive: Grant downloaded 2024-01-02
Inactive: Grant downloaded 2024-01-02
Grant by Issuance 2024-01-02
Letter Sent 2024-01-02
Inactive: Cover page published 2024-01-01
Pre-grant 2023-11-01
Inactive: Final fee received 2023-11-01
Letter Sent 2023-10-11
Notice of Allowance is Issued 2023-10-11
Inactive: Q2 passed 2023-10-06
Inactive: Approved for allowance (AFA) 2023-10-06
Amendment Received - Voluntary Amendment 2023-09-20
Amendment Received - Voluntary Amendment 2023-09-20
Examiner's Interview 2023-09-19
Amendment Received - Response to Examiner's Requisition 2023-06-05
Amendment Received - Voluntary Amendment 2023-06-05
Examiner's Report 2023-02-03
Inactive: Report - No QC 2023-01-31
Amendment Received - Response to Examiner's Requisition 2022-09-29
Amendment Received - Voluntary Amendment 2022-09-29
Examiner's Report 2022-08-11
Inactive: Report - No QC 2022-07-19
Letter Sent 2021-07-09
Request for Examination Received 2021-06-25
Request for Examination Requirements Determined Compliant 2021-06-25
All Requirements for Examination Determined Compliant 2021-06-25
Change of Address or Method of Correspondence Request Received 2020-11-18
Common Representative Appointed 2020-11-07
Change of Address or Method of Correspondence Request Received 2020-05-25
Inactive: Cover page published 2019-12-10
Common Representative Appointed 2019-10-30
Common Representative Appointed 2019-10-30
Application Published (Open to Public Inspection) 2019-06-22
Inactive: First IPC assigned 2018-03-06
Inactive: IPC assigned 2018-03-06
Inactive: IPC assigned 2018-03-06
Inactive: IPC assigned 2018-03-06
Inactive: IPC assigned 2018-03-06
Inactive: IPC assigned 2018-03-06
Inactive: IPC assigned 2018-03-06
Inactive: IPC assigned 2018-03-06
Inactive: IPC assigned 2018-03-06
Inactive: IPC assigned 2018-03-06
Filing Requirements Determined Compliant 2018-01-15
Inactive: Filing certificate - No RFE (bilingual) 2018-01-15
Letter Sent 2018-01-12
Application Received - Regular National 2018-01-04

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 2023-12-19

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Application fee - standard 2017-12-22
Registration of a document 2017-12-22
MF (application, 2nd anniv.) - standard 02 2019-12-23 2019-11-27
MF (application, 3rd anniv.) - standard 03 2020-12-22 2020-09-30
Request for examination - standard 2022-12-22 2021-06-25
MF (application, 4th anniv.) - standard 04 2021-12-22 2021-11-09
MF (application, 5th anniv.) - standard 05 2022-12-22 2022-11-07
Final fee - standard 2023-11-01
MF (application, 6th anniv.) - standard 06 2023-12-22 2023-12-19
MF (patent, 7th anniv.) - standard 2024-12-23 2024-10-23
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
PRODUITS NATURASENCE INC.
Past Owners on Record
BARBARA J. JOHNSTON
LYNDA THERRIEN BERTHIAUME
MOLLY SHARMA
SAMUEL GLEN
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 2023-06-05 3 151
Claims 2023-09-20 3 152
Cover Page 2023-12-05 1 42
Description 2017-12-22 11 366
Abstract 2017-12-22 1 26
Claims 2017-12-22 6 195
Cover Page 2019-12-10 1 41
Description 2022-09-29 11 514
Claims 2022-09-29 3 150
Confirmation of electronic submission 2024-10-23 1 60
Filing Certificate 2018-01-15 1 205
Courtesy - Certificate of registration (related document(s)) 2018-01-12 1 106
Reminder of maintenance fee due 2019-08-26 1 111
Courtesy - Acknowledgement of Request for Examination 2021-07-09 1 434
Commissioner's Notice - Application Found Allowable 2023-10-11 1 578
Amendment / response to report 2023-06-05 17 645
Interview Record 2023-09-19 1 15
Amendment / response to report 2023-09-20 6 188
Final fee 2023-11-01 4 161
Electronic Grant Certificate 2024-01-02 1 2,527
Request for examination 2021-06-25 4 165
Examiner requisition 2022-08-11 4 238
Amendment / response to report 2022-09-29 17 1,265
Examiner requisition 2023-02-03 5 279